At PDA/FDA Joint Regulatory Conference 2026, PCI Pharma's Bassler details how a QMS overhaul turned an FDA 483 into stronger quality culture.
|Articles|January 1, 2003
- Pharmaceutical Technology-01-01-2003
- Volume 27
- Issue 1
Pharmaceutical Pricing and Innovation Key Issues for 2003
Author(s)Jill Wechsler
The establishment of a Medicare pharmacy benefit tops the to-do list of industry-related policy issues for 2003.
Advertisement
Articles in this issue
over 23 years ago
Procedures: Improving Their Qualityover 23 years ago
Drug-Carrier Screening on a Chipover 23 years ago
Outsourcing Outlookover 23 years ago
Pack EXPO International 2002 Proves Worth the Tripover 23 years ago
Analysis of the Indian Pharmaceutical IndustryAdvertisement
Related to this article
Advertisement
Advertisement